Articles from Biocartis NV

Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay

PRESS RELEASE 02/04/2025, 07:00 CEST

By Biocartis NV · Via GlobeNewswire · April 2, 2025

Press Release Biocartis NV: Biocartis Announces Multiple Abstracts Demonstrating the Impact of Idylla™ in Oncology Diagnostics to be Presented at USCAP 2025 Annual Meeting

PRESS RELEASE 18/03/2025, 07:00 CET

By Biocartis NV · Via GlobeNewswire · March 18, 2025

Press Release Biocartis NV: Biocartis announces new data on early CAR-T vector load assessment with Idylla™ presented at ASTCT: A Potential Breakthrough in LBCL Treatment Monitoring

PRESS RELEASE - 14/02/2025, 09:30 CET

By Biocartis NV · Via GlobeNewswire · February 14, 2025

Press Release Biocartis NV: Biocartis appoints Randy Polonsky as Chief Financial Officer

PRESS RELEASE - 05/11/2024, 18:15 CET

By Biocartis NV · Via GlobeNewswire · November 5, 2024

Press Release Biocartis NV: Biocartis announces six Idylla™ abstracts to be presented at AMP 2024 Annual Meeting

PRESS RELEASE - 23/10/2024, 07:00 CEST

By Biocartis NV · Via GlobeNewswire · October 23, 2024

Press release Biocartis NV: Biocartis appoints renowned precision oncology expert, Dr. W. Michael Korn, as Chief Medical and Scientific Officer

PRESS RELEASE - 13/08/2024, 16:00 CEST

By Biocartis NV · Via GlobeNewswire · August 13, 2024

Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing

PRESS RELEASE - 10/06/2024, 07:00 CEST

By Biocartis NV · Via GlobeNewswire · June 10, 2024

Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region

PRESS RELEASE - 06/05/2024, 07:00 CEST

By Biocartis NV · Via GlobeNewswire · May 6, 2024

Press release Biocartis Group NV: Biocartis Announces Nine Idylla™ Studies to be Published at Upcoming AMP 2022 Annual Meeting

PRESS RELEASE: 31 October 2022, 17:40 CET

By Biocartis NV · Via GlobeNewswire · October 31, 2022